Lateefa Jamal Abdulla Al Marzooqi is a pharmacovigilance leader and regulatory pharmacist based in Abu Dhabi, United Arab Emirates. She currently serves as Section Head of Pharmacovigilance and Drug Education at the Department of Health – Abu Dhabi, where she leads strategic initiatives to strengthen medication safety and pharmacovigilance systems across the emirate.

With extensive expertise in drug safety surveillance, Lateefa oversees the monitoring and regulatory assessment of adverse drug reactions, adverse events following immunization, medication errors, and medical device vigilance reports. She has played a pivotal role in shaping Abu Dhabi’s pharmacovigilance ecosystem, including establishing the Abu Dhabi Pharmacovigilance Network (ADPVN) and leading the development of key regulatory policies related to safety alerts, recalls, and vigilance reporting standards.

Lateefa also led the establishment and management of a 24/7 Poison and Drug Information Service in Abu Dhabi and supervised national vaccine safety surveillance during the COVID-19 pandemic through the creation of a dedicated AEFI call center . Her work focuses on strengthening data-driven safety monitoring systems and integrating digital reporting tools to enhance regulatory decision-making and patient safety outcomes.

She holds, bachelor’s degree in pharmacy from Dubai Pharmacy College and postgraduate diplomas in Regulatory Affairs and Clinical Research, Drug Safety and Pharmacovigilance from the Academy of Applied Pharmaceutical Sciences in Toronto, Canada, she was a fellow in ISMP Canada , hold Johns Hopkins Patient Safety Certificate Program and master certificate in healthcare management and services.

Lateefa is actively engaged in international medication safety collaborations and contributes to global pharmacovigilance discussions with regulatory and patient safety networks.